Curcuminoid Drug Interactions

Total Page:16

File Type:pdf, Size:1020Kb

Curcuminoid Drug Interactions Author’s copy! Any use beyond the limits of copyright law without the consent of the publisher is prohibited and punishable. This applies in particular to duplications, translations, Special | Curcuminoids microfilming as well as storage and processing in electronic systems. Peer-reviewed | Manuscript received: May 17, 2015 | Revision accepted: August 17, 2015 Curcuminoid drug interactions Alexa Kocher, Christina Schiborr, Jan Frank, Stuttgart Introduction Summary Curcuminoids are lipiphilic secondary The secondary plant metabolite curcumin and the related curcuminoids may be plant metabolites isolated from the valuable in the prevention and treatment of many different degenerative disea- roots of the plant Curcuma longa ses. As curcuminoids are often taken as supplements by some population groups, (turmeric) ( see SCHIBORR et al., it may be asked whether this can lead to changes in the pharmacokinetics or phar- page M636 [1]) and consist of ca. 77 % macodynamics of other drugs taken at the same time. It is particularly important curcumin, 17 % demethoxycurcumin to clarify this issue, as native curcumin only exhibits low bioavailability, but many and 6 % bis-demethoxycurcumin [2]. novel formulations are being developed that enhance its absorption in the small Because of their many health suppor- intestine and thus lead to higher concentrations of the active drug. Cell culture ting activities, they have long been and animal studies have shown that native curcumin can affect xenobiotic meta- used in traditional Chinese medicine bolizing enzymes. There are also effects on the pharmacokinetics of active sub- for the treatment of respiratory di- stances in animal studies and in men. On the other hand, it has not been shown sease, anorexia, diabetic wounds or that curcumin has any adverse effects on the pharmacological activity of other for digestive disorders [3]. Curcumin drugs. However, it must be emphasized that these studies are preliminary rather supplements are freely commercially than conclusive and must be supported by larger scale investigations. It has also available, mostly as capsules or tab- not been investigated whether the formulations with better bioavailability can lets; many people take them to im- influence the pharmacokinetics of other drugs. prove their health. Keywords: curcumin, curcuminoids, turmeric, drug interactions, safety, drug The oral bioavailability of curcumin is low, i.e. it is poorly absorbed, and rapidly metabolized and eliminated. For this reason, curcumin formula- tions with better bioavailability are being sold increasingly often; these give much higher plasma concentra- Older and chronically ill people often attempt to improve their health tions of curcumin than native curcu- min [1]. by taking food supplements. Thus they often take drugs together with People who take curcumin supple- plant extracts that might influence the effects of these drugs. In the ments are often older or chronically present article, we describe the evidence for drug interactions involving ill and have to take medicines every the secondary plant metabolite curcumin and the related curcumioids. day. This article therefore examines Citation: Explanation of terms used: Kocher A, Schiborr C, Frank J (2015) Curcuminoid drug inter- An active substance or drug is the substance in a medicine which actions. Ernahrungs Umschau mediates or causes the active effect. The medicine may also contain one or several additional substances (“excipients”) for different for- 62(11): 188–195 mulations (e.g. tablet or syrups). The preparation of different drug This article is available online: formulations is known as pharmacy and can have a major influence DOI: 10.4455/eu.2015.037 on drug activity. 188 Ernaehrungs Umschau international | 11/2015 whether there is published scientif- is often described by the following availability. Because of incomplete ic evidence for interactions between parameters: absorption and metabolism, an curcuminoids – primarily curcumin • physiological half-time of elimina- orally or enterally administered drug – and medicines (or their active sub- tion (t1/2), has a bioavailability of < 100 %. stances) which may modify their ac- • time to reach the maximum tivity. The focus is on the pharmaco- plasma concentration (tmax), kinetics of various drugs. The effects • maximal plasma concentration The so-called “therapeutic index” of curcumin on drug pharmacodyna- (Cmax) and is an important parameter in asses- mics are mentioned in passing. • area under the concentration time sing the safety of a drug. This is the curve (“area under the curve”, interval between the minimal active AUC) (• Figure 1). and minimal toxic concentration of Key terms the drug [5]. The physiological half-time of eli- Food-drug interaction mination (t1/2) is the time needed for We will use the term “food-drug in- the (plasma) concentration of the ac- Pharmacodynamics (= what the ac- teraction” for changes in the phar- tive substance to sink to 50 % of the tive substance does to the organism) macokinetics or pharmacodynamics initial value. The rate of absorption signifi es the biological activity of an of a drug caused by the uptake of a of a substance can be estimated from active substance [6]. food component [4]. the time (tmax) to reach the max- imum plasma concentration (Cmax). Food-drug interactions can lead to The area under the concentration time changes in pharmacokinetics and/ The term “pharmacokinetics” (= curve (“area under the curve”, AUC) or pharmacodynamics and modify what the organism does to the ac- refl ects the subject‘s exposure to the the activity and safety profi le of the tive substance) means the sum of drug or nutrient. medicine (side effects = adverse drug all processes to which the active The “bioavailability” describes the reactions) in this way. Thus, a re- substance is subject in the body proportion of a drug or nutrient that duction in the bioavailability of a and includes its absorption, distri- is available to systemic circulation in drug can lead to treatment failure. bution, metabolism and excretion. the body. Intravenous administra- On the other hand, enhanced bio- The kinetic profi le of a substance tion is defi ned as giving 100 % bio- availability can lead to enhanced ac- Maximal plasma Side effects (plasma concentration (Cmax) concentration too high) Therapeutic index Substanz X Treatment failure Substance X [nmol/L Plasma] (plasma concentration too low) [mmol/l plasma] Time of maximal plasma Time [h] concentration (tmax) Fig. 1: Typical plasma concentration time curve for a drug The pharmacokinetics of a substance can be determined by measuring the maximal concentration (Cmax), the time to reach the max- imal concentration (tmax), and the “area under the curve” (AUC), which refl ects individual exposure to a substance. The therapeutic index describes the concentration range in which the drug is therapeutically active and lies between the minimal effective and the minimal toxic concentrations of the active substance. Ernaehrungs Umschau international | 11/2015 189 Special | Curcuminoids tivity and also possibly to enhanced enzymes. Incubation of human absorption and transport proces- drug toxicity (• Figure 1) [4]. These liver cell microsomes with a cur- ses and metabolism [10]. The op- interactions can be split into various cuminoid extract led to 50 % in- posite effect was observed in a categories: hibition of different CYP450s at rat model. In this study, the ani- (1) Inactivation of the drug ex vivo, the following concentrations: mals were fed for 2 weeks with i.e. outside the body, CYP2C19, 7.4 μmol/L; CYP2B6, 1 % curcumin per kg feed and then (2) Interactions which modify 9.4 μmol/L; CYP2C9, 13.5 the microsomes were isolated from presystemic transport (absorp- μmol/L; CYP3A, 25.3 μmol/L. the intestine and liver. The UGT tion), CYP2D6, CYP1A2 and CYP2E1 activity increased 5.4-, 6.7- and (3) Interactions which modify syste- were only very weakly inhibited 7.2-fold in the proximal, middle mic metabolism and drug elimi- [10]. On the other hand, another and distal sections of the small in- nation, and in vitro study with microsomes testine, respectively. In comparison (4) Interactions which directly influ- found that CYP3A4 and 2D6 were to the control, there was a 3.1-fold ence drug activity (pharmacody- not inhibited by up to 58.3 μmol/L increase in the large intestine and a namics), e.g. by binding to tar- curcumin, while 58.3 μmol/L cur- 1.5-fold increase in the liver [13]. get structures such as receptors. cumin inhibited CYP2C9 and 2C8 by 10.5 % and 22.5 %, respective- ly [11]. The effects of curcumin Effect of curcumin on mem- Effect of curcuminoids on can also be tissue-specific. After brane transporters enzymes that metabolize feeding rats for 4 days with cur- As the present article cannot pursue foreign compounds cumin (60 mg/kg body weight all interactions between curcumin [BW]), there was a 42 % reduction and membrane transport proteins, The following cell culture and ani- in the intestinal content of CYP3A the discussion will be restricted to mal studies examined the influence protein, but a 91 % increase in the multidrug resistance protein 1 of curcumin on enzymes that me- liver content of this protein [12]. (MDR1; also known as P-glycopro- tabolize foreign compounds. These tein [P-Gp]). MDR1 is a transport studies provide preliminary evidence protein in the plasma membrane and Influence of curcumin on phase that curcumin might influence drug is mainly expressed in the liver, kid- II metabolisms metabolism. neys, gastrointestinal tract and the Curcumin can also affect phase II blood-brain barrier. In the liver, it is enzymes. Thus 12.1 μmol/L and 5.2 expressed on the canalicular apical Modulation of phase I μmol/L of a curcuminoid extract lead side of the membrane (towards the metabolism by curcumin to 50 % inhibition of UGT and SULT lumen), in the intestine on the apical Microsomes are membrane frag- activity, respectively, in colon adeno- membrane of the mucosal cells and in ments of the endoplasmic reticu- carcinoma cells (LS180 cells), an the kidney on the brush border mem- lum that contain active CYP450 intestinal cell model to examine brane of the proximal tubulus cells.
Recommended publications
  • Chemical Composition and Product Quality Control of Turmeric
    Stephen F. Austin State University SFA ScholarWorks Faculty Publications Agriculture 2011 Chemical composition and product quality control of turmeric (Curcuma longa L.) Shiyou Li Stephen F Austin State University, Arthur Temple College of Forestry and Agriculture, [email protected] Wei Yuan Stephen F Austin State University, Arthur Temple College of Forestry and Agriculture, [email protected] Guangrui Deng Ping Wang Stephen F Austin State University, Arthur Temple College of Forestry and Agriculture, [email protected] Peiying Yang See next page for additional authors Follow this and additional works at: http://scholarworks.sfasu.edu/agriculture_facultypubs Part of the Natural Products Chemistry and Pharmacognosy Commons, and the Pharmaceutical Preparations Commons Tell us how this article helped you. Recommended Citation Li, Shiyou; Yuan, Wei; Deng, Guangrui; Wang, Ping; Yang, Peiying; and Aggarwal, Bharat, "Chemical composition and product quality control of turmeric (Curcuma longa L.)" (2011). Faculty Publications. Paper 1. http://scholarworks.sfasu.edu/agriculture_facultypubs/1 This Article is brought to you for free and open access by the Agriculture at SFA ScholarWorks. It has been accepted for inclusion in Faculty Publications by an authorized administrator of SFA ScholarWorks. For more information, please contact [email protected]. Authors Shiyou Li, Wei Yuan, Guangrui Deng, Ping Wang, Peiying Yang, and Bharat Aggarwal This article is available at SFA ScholarWorks: http://scholarworks.sfasu.edu/agriculture_facultypubs/1 28 Pharmaceutical Crops, 2011, 2, 28-54 Open Access Chemical Composition and Product Quality Control of Turmeric (Curcuma longa L.) ,1 1 1 1 2 3 Shiyou Li* , Wei Yuan , Guangrui Deng , Ping Wang , Peiying Yang and Bharat B. Aggarwal 1National Center for Pharmaceutical Crops, Arthur Temple College of Forestry and Agriculture, Stephen F.
    [Show full text]
  • 9 Preparation Process of Curcuminoid Powder From
    PREPARATION PROCESS OF CURCUMINOID POWDER FROM TURMERIC RHIZOME (Curcuma longa domestica, Vahl) AND ITS CHARACTERISTIC AS FOOD INGREDIENTS PROSES PEMBUATAN BUBUK CURCUMINOID DARI RIMPANG KUNYIT (Curcuma longa domestica, Vahl) DAN KARAKTERISTIKNYA SEBAGAI BAHAN INGREDIEN PANGAN Agus Sudibyo, Tiurlan Farida Hutajulu, dan Maman Sukiman Balai Besar Industri Agro Jl. Ir.H. Juanda No.11 Bogor Email: [email protected] Diterima: 14-03-2017 Direvisi: 29-01-2018 Disetujui: 26-02-2018 ABSTRAK Studi pada proses pembuatan bubuk curcuminoid dari akar kunyit (Curcuma longa domestica Vahl dan karakteristiknya sebagai bahan pangan telah dilakukan. Hasil percobaan menunjukkan bahwa jenis pelarut, perbandingan antara padatan-larutan dan suhu ekstrasi yang digunakan berpengaruh terhadap rendemen kandungan curcuminoid. Kandungan curcumnoid berkisar antara 11,96% hingga 14,01% (untuk ekstrasi dengan pelarut ethanol 60%), berkisar antara 12,91% hingga 15,20% (ekstrasi dengan pelarut ethanol 80%), dan berkisar antara 3,85 hingga 7,19% (ekstrasi dengan pelarut ethanol 50%). Hasil penelitian menunjukkan bahwa nilai tertinggi dan terbaik kandungan total senyawa fenol tercatat pada ekstrasi dengan ethanol (perbandingan S/L 1 : 50 dan suhu ekstrasi 60oC) dengan nilai 148,99 mg GAE/100 g sedang nilai terendah tercatat untuk ekstrasi menggunakan pelarut 50% (perbandingan S/L 1 : 30) dan suhu ekstrasi 30oC dengan nilai 101,43 mg GAE/100 g. Hasil penelitian juga menunjukkan bahwa nilai tertinggi aktifitas antioksidan tercatat pada ekstraksi menggunakan ethanol 80% dan menggunakan bahan kunyit kering sebanyak 15,0 g dengan nilai 47,65% ; sedang nilai terendah sebagai aktifitas antioksidan pada ekstrasi menggunakan ethanol 50% dan menggunakan bahan kunyit kering sebanyak 1,50 g dengan nilai 20,04%.
    [Show full text]
  • Effects of UVA-Light on Color Transition of Anthocyanin And
    3A-6 日本色彩学会誌 第 42 巻 第 3号 (2018 年)JCSAJ Vol.42 No.3 Effects of UVA-light on Color Transition of Anthocyanin and Curcumin Dyes and Possible Application of Light-Activated Oxygen Indicator in Food Package Kanpicha Suwannawatanamatee Rajamangala University of Technology Thanyaburi, RMUTT Surachai Khankaew Rajamangala University of Technology Thanyaburi, RMUTT Chanprapha Phuangsuan Color Research Center, RMUTT KeywordsOxygen Indicator,Intelligent Packaging, Anthocyanin is water-solution pigment ar- Naturals Dyes ranged flavonoids. The color of anthocyanin can be changed by pH conditions. Normally, plants which are 1.Introduction blue, purple, pink and red color can be found antho- Active and intelligent packaging is novel food cyanin in vacuole. Anthocyanin can naturally apply as packaging technology which is rapidly increasing in a dye and additive for food and beverage industry. this century. The active packaging (AP) is packaging Curcumin and curcuminoid are natural dye that can material that can protect the quality or safety of the be found in the root such turmeric. Curcumin is a pol- products such as ethylene absorber or inhibitor, mod- yphenol substance which appears yellow and orange ified atmosphere packaging (MAP) and oxygen ab- colors. sorber. Meanwhile, the intelligent packaging (IP) that This research investigated the effects of has a function to monitor or track the change of exter- UVA-light on the color transition of anthocyanin and nal or internal environment of packages and com- curcumin which were used as dyes and possibly ap- municate positions of products to customers such as plied as either an OI or other indicators for food indi- ripeness indicator (RI), ready to serve indicator (RSI), cator application.
    [Show full text]
  • Rapid Analysis of Curcuminoids in Turmeric Extract Using the Agilent 1290 Infinity LC and STM Columns
    Rapid Analysis of Curcuminoids in Turmeric Extract Using the Agilent 1290 Infinity LC and STM Columns Application Note Author Abstract Adam Horkey A method has been developed for the separation of curcuminoids in turmeric using Schwabe North America an Agilent 1290 Infinity LC and STM column. This method is proven to provide rapid Green Bay, WI cycle times with good resolution, over the traditional USP method. USA Introduction Experimental Turmeric is derived from the plant Curcuma Longa , a member Sample preparation of the ginger family. Curcumin is a natural extract from the A 25-mg amount of sample extract was dissolved in 50 mL of Turmeric spice, and has been used for many centuries in India reagent alcohol by sonication. The sample was further diluted and Asia because of its numerous potential benefits. 1:25 in reagent alcohol. Curcumin has been used since ancient times to treat disor - ders such as arthritis, digestive problems, and urinary issues. The sample extract was obtained from Natural Remedies in It can also be used to treat low energy and a variety of skin Karnataka, India. and wound conditions. Some researchers believe curcumin can be helpful in treating Alzheimer’s disease, diabetes, The sample was run with an Agilent 1290 Infinity LC System, allergies, and arthritis [1]. using the method parameters listed in Table 1. These results were compared to those of the same analysis, using the USP Separation and quantification of curcuminoids can be accom - method parameters listed in Table 2 [2]. plished with liquid chromatography. Advancements in LC instrumentation and column design have drastically increased Table 1.
    [Show full text]
  • Curcuminoid Analysis of Hawaii-Grown Turmeric
    CURCUMINOID ANALYSIS OF HAWAII-GROWN TURMERIC (Curcuma longa) BY HIGH- PERFORMANCE LIQUID CHROMATOGRAPHY AND INVESTIGATION OF COLOR RELATIONSHIP WITH CURCUMINOID CONTENT FOR TOTAL CURCUMINOID ESTIMATION A THESIS SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERSITY OF HAWAI’I AT MĀNOA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN FOOD SCIENCE AUGUST 2020 By Justin Calpito Thesis Committee: Jon-Paul Bingham, Chairperson Theodore Radovich Daniel Owens Keywords: Turmeric, Curcuma longa, curcumin, curcuminoid ©2020, Justin Calpito ii DEDICATION I dedicate this thesis to the farmers, scientists, and workers of Hawaii who seek to improve the sustainability and value of Hawaii’s agriculture. iii ACKNOWLEDGEMENTS I would first like to acknowledge my family for have endured with me through my lengthy college career and supported me with food and money. Secondly, I thank my friends who have stood with me and encouraged me constantly to finish this thesis. My research could not be completed without the efforts of my professors and lab mates, who have helped me through every step of the way, from harvesting and cleaning the turmeric to maintaining the intricate parts of the HPLC machine. I would also like to thank the late Dr. Alvin Huang, who imparted to me his interest in food chemistry and its applications to Hawaii’s food industry. Lastly, I would like to thank God, who has helped me cultivate the patience and endurance needed to finish this race. iv ABSTRACT An HPLC method was designed to analyze turmeric (Curcuma longa) cultivars for curcuminoid contents curcumin, demethoxycurcumin and bis-demethoxycurcumin, and the sum of these were taken as total curcuminoids (TC).
    [Show full text]
  • Formulation and Evaluation of Curcumin Loaded Solid Lipid Nanoparticles by Hot Homogenization Method by Employing Glyceryl Monostearate
    ISSN: 2455-2631 © December 2018 IJSDR | Volume 3, Issue 12 FORMULATION AND EVALUATION OF CURCUMIN LOADED SOLID LIPID NANOPARTICLES BY HOT HOMOGENIZATION METHOD BY EMPLOYING GLYCERYL MONOSTEARATE 1Shruti Madderla, 2Dr. P.Tripura sundari RBVRR Women’s College of Pharmacy, Osmania University, Barkatpura, Hyderabad, India. ABSTRACT: Curcumin was naturally occurring agent with poor solubility also with a bioavailability of 3%. It is useful in many potential pharmacological effects including anti-inflammatory, antibacterial, antioxidant and anticancer activities. It was also proved against cardiovascular disease, Alzheimer’s disease, liver problems, rheumatic arthritis, diabetics, Parkinson’s disease and neurological disorders. To enhance its solubility, permeability and bioavailability nanoparticle technology is very much useful. In the present work attempts were made to prepare the SLNs of curcumin by employing Glyceryl monostearate (GMS) as solid lipid, Tween 80and soya lecithin as hydrophilic and lipophilic surfactants respectively. The five prepared formulations were evaluated for various parameters like entrapment efficiency, In Vitro drug release, particle size, Zeta potential and SEM analysis. Among all the Preparations G3 formulation was best in terms of Drug content of 85.5%, Entrapment efficiency of 72.2%, Drug release of 64.0%, Particle size of 393.1 nm with Zeta potential of -15.1 mV and was also in accordance with particle size in nano range by SEM analysis in Hot Homogenization. The present study conclusively demonstrated that the solubility of drug was improved by entrapment of drug into solid lipid carrier which led to prolongation of drug release. KEYWORDS: Glycerol Monostearate (GMS), Solid lipid nanoparticles (SLNs), Hot Homogenization Method (HHM). 1. INTRODUCTION The enhancement of solubility and oral bioavailability of poorly water soluble drugs remain one of the most challenging aspects of drug development.
    [Show full text]
  • The Effect of Rice Bran Wax on Physicochemical Properties of Curcuminoid-Loaded Solid Lipid Nanoparticles
    TJPS Vol.40 (Special Issue) 2016 Thai Journal of Pharmaceutical Sciences (TJPS) Journal homepage: http://www.tjps.pharm.chula.ac.th The effect of rice bran wax on physicochemical properties of curcuminoid-loaded solid lipid nanoparticles Tangkhajornchaisak P1, Rojsitthisak P2, Tiyaboonchai W3, Wattanaarsakit P1,* 1 Department of Pharmaceutics and Industrial Pharmacy and 2Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. 3 Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Pitsanulok 65000, Thailand. Keywords: Curcuminoid, High pressure homogenization, Rice bran wax, Solid lipid nanoparticles Objectives: The aim of this study was to explore the potential of using rice bran wax as a natural lipid composition for curcuminoid-loaded solid lipid nanoparticles. Methods: Blank solid lipid nanoparticle (SLN) formulations of three lipid types and concentrations; rice bran wax (RB), glyceryl behenate (GB) and cetyl palmitate (CP) at 2.5, 5 and 7.5%w/w were studied. SLN were prepared by a high pressure homogenization technique and characterized on their particle size, polydispersity index and zeta potential. SLN physical stability was also observed during storage. Curcuminoid-loaded SLN (C-SLN) were prepared and determined their physical characteristics and percentage of drug entrapment. Results: The results showed that particle size of all SLN formulations ranged in nanosize with narrow size distribution and low zeta potential which indicating a good physical stability. SLN with RB had smaller size compared to GB and CP. The mean particle size of RB-SLN was slightly increased when a lipid concentration was increased from 2.5 to 7.5%w/w.
    [Show full text]
  • GRAS Notice 822, Curcumin
    GRAS Notice (GRN) No. 822 https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory ~ . la AIBMR Life Sciences, Inc. Notice to US Food and Drug Administration of the Conclusion that the Intended Use of Curcumin is Generally Recognized as Safe Submitted by the Notifier: Laurus Labs Private Ltd. 2nd Floor, Serene Chambers Road No: 7 Banjara Hills, Hyderabad-500 034 Andhra Pradesh, India Prepared by the Agent of the Notifier: AIBMR Life Sciences, Inc 2800 E. Madison, Suite 202 Seattle WA 98112 November 15, 2018 fPd~©~~~~lD) NOV 2 6 2018 OFFICE OF FOOD ADDITIV!: SAFETY ,lAIBMR Life Sciences. Inc. Table of Contents Part 1: Signed Statements and Certification ..................................................................... 4 1.1 Submission of GRAS Notice ................................................................................. 4 1.2 Name and Address of the Notifier and Agent of the Notifier.. ................................ 4 1.3 Name of the Substance .......................................................................................... 4 1.4 Intended Conditions of Use ................................................................................... 5 1.5 Statutory Basis for GRAS Conclusion ................................................................... 5 1.6 Not Subject to Premarket approval ........................................................................ 5 1. 7 Data and Information Availability Statement ......................................................... 5 1.8 Exemption from Disclosure
    [Show full text]
  • Antioxidant Efficacy of Curcuminoids from Turmeric ( Curcuma Longa L
    Downloaded from British Journal of Nutrition (2009), 102, 1629–1634 doi:10.1017/S0007114509990869 q The Authors 2009 https://www.cambridge.org/core Antioxidant efficacy of curcuminoids from turmeric (Curcuma longa L.) powder in broiler chickens fed diets containing aflatoxin B1 Nisarani K. S. Gowda1*, David R. Ledoux2, Goerge E. Rottinghaus2, Alex J. Bermudez2 and Yin C. Chen2 . IP address: 1National Institute of Animal Nutrition and Physiology, Bangalore 560030, India 2Fusarium/Poultry Research Laboratory, University of Missouri, Columbia, MO 65211, USA 170.106.33.22 (Received 6 November 2008 – Revised 21 May 2009 – Accepted 28 May 2009 – First published online 17 August 2009) , on A 3-week-feeding study (1–21 d post-hatch) was conducted to evaluate the efficacy of total curcuminoids (TCMN), as an antioxidant, to amelio- 30 Sep 2021 at 21:30:52 rate the adverse effects of aflatoxin B1 (AFB1) in broiler chickens. Turmeric powder (Curcuma longa L.) that contained 2·55 % TCMN was used as a source of TCMN. Six cage replicates of five chicks each were assigned to each of six dietary treatments, which included: basal diet; basal diet supplemented with 444 mg/kg TCMN; basal diet supplemented with 1·0 mg/kg AFB1; basal diet supplemented with 74 mg/kg TCMN and 1·0 mg/kg AFB1; basal diet supplemented with 222 mg/kg TCMN and 1·0 mg/kg AFB1; basal diet supplemented with 444 mg/kg TCMN and 1·0 mg/kg AFB1. The addition of 74 and 222 mg/kg TCMN to the AFB1 diet significantly (P,0·05) improved weight gain and feed efficiency.
    [Show full text]
  • (Curcuma Longa Linn.) Ethanol
    Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2018, 10(12): 51-57 ISSN : 0975-7384 Research Article CODEN(USA) : JCPRC5 Determination of Total Curcuminoid Content and Free Radical Scavenging Activity of Turmeric (curcuma longa linn.) Ethanol Extract with Different Soil type Sing dpph (1,1- diphenyl-2-picrylhydrazyl) Any Guntarti* and Romadhina Nurficahyanti Fakultas Farmasi Universitas Ahmad Dahlan Yogyakarta, Jl. Dr. Soepomo SH, Janturan, Warungboto, Yogyakarta, Indonesia _____________________________________________________________________________ ABSTRACT Natural antioxidants such as turmeric rhizome (Curcuma longa Linn.) Are known to have antioxidant activity against free radicals because they contain bioactive compounds in the form of curcumin. This study aims to determine the total levels of curcuminoids expressed as equivalent to curcumin (EK) and antioxidant activity using the DPPH method (1,1 diphenyl 2 picrylhydrazyl). Turmeric extract was obtained by using Soxhlet using ethanol solvent p.a. Curcuminoid identification in extracts and antioxidant activity by Thin Layer Chromatography (TLC) test. While the total levels of curcuminoids and antioxidant activity were determined by visible spectrophotometry. Quantitative analysis of total levels of curcuminoids and antioxidant activity was carried out by determining the correlation coefficient value of the linear regression equation obtained. The qualitative test results showed that ethanol extract of turmeric from Alfisol and Inceptisol soil types positively contained curcuminoid compounds and had antioxidant activity. The total curcuminoid content in C.longa L. ethanol extract from Alfisol soil was 11.24 ± 0.409% (EK) while from Inceptisol soil type was 5.87 ± 0.174% (EK). Standard antioxidant activity of curcumin, ethanol extract of C.longa L. from Alfisol and Inceptisol soil types ES50 values of were 6.17 μg / mL, 29.56 μg / mL, and 39.08 μg / mL, respectively.
    [Show full text]
  • Preparation of Curcuminoid Powder from Turmeric Root (Curcuma Longa Linn) for Food Ingredient Use
    Kasetsart J. (Nat. Sci.) 44 : 123 - 130 (2010) Preparation of Curcuminoid Powder from Turmeric Root (Curcuma longa Linn) for Food Ingredient Use Vipa Surojanametakul*, Prajongwate Satmalee, Janpen Saengprakai, Dalad Siliwan and Ladda Wattanasiritham ABSTRACT The tumeric (Curcuma longa Linn) Chan variety possessed higher curcuminoid than the Dang- Siam variety. The result showed that the extracting solvent could significantly alter the curcuminoid as well as the total polyphenol content of the turmeric extract. Recommended conditions for curcuminoid extract from turmeric were: ethanol, solid:liquid ratio 1:50, at 70°C for 2 hr. Preparation of curcuminoid powder from turmeric extract was performed by entrapment of the natural turmeric compound “curcuminoid” with a polysaccharide, carboxymethyl cellulose, as a complex formation and mixed with maltodextrin, prior to drying. The curcuminoid content in the powder affected the product’s qualities such as color, total phenolic compounds and antioxidant properties. Sensory evaluation of the products, in the form of turmeric tea, revealed that powder containing a level of curcuminoid of 411.28µg/g had the highest acceptance score. It also exhibited high water solubility (15g/100 ml). The total phenolic content and antioxidant capability of the product with the highest acceptance score was 13.27 as mg GAE/g and 14.46 as mg BHAE/g, respectively. The powder had a total plate count of yeast and mold <10 cfu/g and no pathogenic microorganisms were found. Storage of the powder in an aluminum foil bag at room temperature for four months only slightly changed the curcuminoid content, indicating the high stability of the product.
    [Show full text]
  • Curcuma Longa)
    Revista Brasileira de Farmacognosia 25 (2015) 53–60 www.sbfgnosia.org.br/revista Original Article Nanoparticles containing curcuminoids (Curcuma longa): development of topical delivery formulation a b a b,∗ Cristina M. Zamarioli , Rodrigo M. Martins , Emilia C. Carvalho , Luis A.P. Freitas a Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil b Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Núcleo de Pesquisas em Produtos Naturais e Sintéticos, Universidade de São Paulo, Ribeirão Preto, SP, Brazil a r a b s t r a c t t i c l e i n f o Article history: Solid lipid nanoparticles incorporating Curcuma longa L., Zingiberaceae, curcuminoids were produced by Received 12 July 2014 the hot melt emulsion method. A Box–Behnken factorial design was adopted to study the nanoparticles Accepted 3 November 2014 production at different levels of factors such as the percentage of curcuminoids, time of homogeniza- Available online 11 February 2015 tion and surfactant ratio. The optimized nanoparticles were incorporated into hydrogels for stability, drug release and skin permeation tests. The average nanoparticle sizes were 210.4 nm; the zeta poten- Keywords: tial of −30.40 ± 4.16; the polydispersivity was 0.222 ± 0.125. The average encapsulation efficiency of Solid lipid nanoparticles curcumin and curcuminoids was 52.92 ± 5.41% and 48.39 ± 6.62%, respectively. Solid lipid nanocapsules Beeswax were obtained with curcumin load varying from 14.2 to 33.6% and total curcuminoids load as high as Pig skin Curcumin 47.7%. The topical formulation containing SLN-Curcuminoids showed good spreadability and stability when subjected to mechanical stress test remained with characteristic color, showed no phase separa- tion and no significant change in pH.
    [Show full text]